جستجوی استاد راهنمای دانشگاهی

Praveen Bhugraمشاهده پروفایل

مدرس ارشد

• Cardiovascular Pharmacology
• Central Nervous System Pharmacology
• Autonomic Pharmacology
• +۲ مورد دیگر

Dr. Praveen Bhugra is a Senior Lecturer in Pharmacology at the University of Sunderland , where he has taught graduate courses including MPharm since 2006. His expertise spans cardiovascular, central nervous system, and autonomic pharmacology with a focus on receptor regulation in disease states. MSc (Pharmacology) from The Maharaja Sayajirao University of Baroda, India PhD (Medical Pharmacology) from Sardar Patel University, India His research integrates experimental pharmacology, molecular techniques (cell culture, calcium flux analysis), and biochemical approaches. Notably, he supervised PhD candidate Thomas Cherian (awarded 2014) on ureteral motility mechanisms. He authored the widely used textbook MCQs in Pharmacology (2000) and contributed to cardiovascular research during a 2000-2001 Visiting Scientist fellowship at the Institute of Cardiovascular Research, University of Manitoba, Canada. Recent publications (2015-2001) emphasize neurodegenerative pharmacology , hypertension mechanisms , and lipid mediator roles in cardiovascular disease . His work has been recognized with awards from the Indian Pharmacological Society and the International Society for Heart Research. Jaypur Prize (1985-86) C.L. Malhotra Research Prize (1994) Ahmedabad Branch Prizes (1996, 2001) National Academy of Medical Sciences Membership (2000) He has also contributed to public health research on probiotics in Clostridium difficile infection and participated in systematic reviews of substance abuse patterns in youth. Contact: praveen.bhugra@sunderland.ac.uk

• Gut Microbiome
• Clostridioides difficile Infection (CDI)
• Fecal Microbiota Transplantation
• +۳ مورد دیگر

Anna Seekatz is an Assistant Professor in the Department of Biological Sciences at Clemson University, affiliated with the College of Science. Her research focuses on the gut microbiome, particularly its role in health and disease, with emphasis on Clostridioides difficile infection (CDI) and fecal microbiota transplantation (FMT). She received her PhD from the University of Maryland School of Medicine and completed postdoctoral training at the University of Michigan. Education : PhD, Molecular Microbiology and Immunology, University of Maryland School of Medicine, 2013 BS, Cellular and Molecular Biology, Western Washington University, 2006 Research Interests : Dr. Seekatz studies microbial interactions within the gut microbiota, including CDI pathogenesis and FMT mechanisms. Her lab investigates how microbial communities contribute to disease resistance and recovery, with a focus on identifying key species and metabolites involved in CDI clearance. Current projects include characterizing commensal Clostridia and their functional dependencies in the gut environment. Techniques employed include bioinformatics, animal models, and traditional microbiology. Lab & Advising : Her research group includes PhD students Sophie Millard, Clara Flores, Christine Woelfel-Monsivais, and postdoctoral fellow Disha Bhattacharjee. She teaches Pathogenic Bacteriology and a creative inquiry course on commensal Clostridia characterization. Lab Locations : Life Sciences Building 157A (Office), 160F and 172 (Labs).

Derrick Crookمشاهده پروفایل

استاد

• Medical Microbiology
• Antimicrobial Resistance (AMR)
• Genomics
• +۳ مورد دیگر

Professor Derrick Crook is a leading academic in medical microbiology at the Nuffield Department of Medicine , University of Oxford, while also serving as an Infectious Diseases Physician at Oxford University Hospitals NHS Trust. He combines clinical practice with cutting-edge research on pathogen genomics and antimicrobial resistance. Education : Medicine (University of Witwatersrand); Diploma of Tropical Medicine (London); Internal Medicine Specialization (University of Virginia); Infectious Diseases Fellowship (Tufts New England Medical Center) His research focuses on translating whole pathogen sequencing into clinical practice, studying Mycobacterium tuberculosis , Escherichia coli , and Clostridium difficile . Key projects include the CRyPTIC program (20-country tuberculosis resistance analysis) and development of AI-powered rapid diagnostics. Recent publications demonstrate his team's leadership in using genomic data to predict drug resistance and analyze disease trends through electronic health records . The research emphasizes practical applications for infection control and antibiotic stewardship. Scientific Contributions : NIHR Health Protection Research Unit Global Pathogen Analysis System (GPAS) Mykrobe Predictor software development As co-director of Oxford Biomedical Research Infection Theme, he leads a multidisciplinary team working to modernize infection diagnostics and treatment approaches.

Amber Martinمشاهده پروفایل

دانشیار بالینی

• Geriatric Pharmacy
• Clinical Pharmacotherapy
• Medication Management
• +۶ مورد دیگر

Amber Martin, Pharm.D., BCPS, is an Associate Clinical Professor at Auburn University Harrison College of Pharmacy. Her professional address is 1330p Walker Building, Auburn, AL 36849, and she can be reached at martiam@auburn.edu. Education: Pharm.D., Auburn University Harrison College of Pharmacy, 2007 Dr. Martin specializes in geriatric pharmacotherapy, COPD management, diabetes treatment, and medication regimen reviews for skilled nursing facilities. She integrates sterile compounding education into the curriculum and coordinates skills laboratory experiences for pharmacy students. Her research focuses on age-related medication challenges, chronic disease management, and interdisciplinary clinical education. She has presented nationally on topics such as diabetes care, geriatric pharmacotherapy, and inhaler techniques for elderly COPD patients, with publications in journals like Current Pharmacy Teaching and Learning and Expert Review of Clinical Pharmacology . Dr. Martin contributes to experiential education through introductory and advanced pharmacy practice experiences (IPPEs/APPEs) and PGY-1 residency training. She collaborates with multidisciplinary teams at East Alabama Medical Center and has delivered regional continuing education lectures on COPD, vitamin D, and GI therapies.

Deirdre Collinsمشاهده پروفایل

پژوهشگر ارشد

• Clostridium difficile Infection
• Infectious Disease Epidemiology
• Molecular Epidemiology
• +۳ مورد دیگر

Dr. Deirdre Collins is an NHMRC Early Career Fellow at Edith Cowan University (ECU), affiliated with the School of Medical and Health Sciences. She collaborates with Professor Thomas Riley's research group at PathWest Laboratory Medicine, QEII Medical Centre. Her primary focus is Clostridium difficile infection epidemiology, molecular diagnostics, and antimicrobial resistance. Dr. Collins holds a PhD from the University of Western Australia (2017) and a Master of Infectious Diseases (2011). Research Interests: Clostridium difficile infection, infectious disease epidemiology, molecular epidemiology, One Health, antimicrobial resistance. Key Projects: Includes a One Health/System Dynamics approach to reducing C. difficile infections (NHMRC Ideas Grant 2022–2025) and studies on environmental sources of C. difficile in hospitals. Her research spans Asia-Pacific regions, emphasizing community and hospital-acquired infections. Notable achievements include: Published over 50 peer-reviewed articles on C. difficile genomics, transmission dynamics, and environmental contamination. Received awards such as the Australasian Epidemiological Association Travel Award (2018) and Vice-Chancellor's Excellence in Research Award (2018). Active in grants totaling over $2M, including NHMRC Early Career Fellowship (2019–2023). Dr. Collins' work bridges laboratory research and public health policy, addressing global health challenges through interdisciplinary collaboration.

• Clostridium difficile
• Healthcare-associated infections
• Infection control
• +۲ مورد دیگر

Vivian Loo is a Professor at the Faculty of Medicine and Health Sciences , McGill University , and an Associate Investigator at the RI-MUHC (Glen site) under the Infectious Diseases and Immunity in Global Health Program . She specializes in hospital epidemiology and infectious disease research. McGill University RI-MUHC, Glen site MUHC (Division of Infectious Diseases) Research Interests Dr. Loo's work focuses on Clostridium difficile infections (CDI) , examining epidemiological risk factors, asymptomatic colonization, environmental control strategies, and rapid diagnostic test evaluation. Her studies address healthcare-associated infection prevention, transmission dynamics, and host-pathogen interactions. Scientific Contributions Her research includes: Epidemiology of CDI acquisition Environmental control measures Diagnostic test optimization Host DNA biomarkers in feces Strain typing effects on detection

Yannick Tremblayمشاهده پروفایل

مدرس

• Bacterial Pathogens
• Biofilm Formation
• Antimicrobial Resistance
• +۳ مورد دیگر

Yannick Tremblay is a Lecturer in the Department of Biochemistry, Microbiology & Immunology at the University of Saskatchewan's College of Medicine. His research focuses on bacterial biofilm formation in pathogens such as Clostridioides difficile and Actinobacillus pleuropneumoniae, emphasizing their roles in public health and veterinary medicine. He holds a PhD from Dalhousie University (2010), MSc and BSc from McGill University (2005 and 2003). Education: PhD in Microbiology and Immunology, Dalhousie University, 2010 MSc in Microbiology, McGill University, 2005 BSc (Agriculture) in Microbiology, McGill University, 2003 Research Interests: Prof. Tremblay investigates biofilm mechanisms in pathogenic bacteria, including environmental persistence, antimicrobial resistance, and vaccine development strategies. His work bridges microbiology, veterinary medicine, and public health, with a focus on understanding how biofilms influence pathogen behavior and treatment efficacy. Recent Research Trends: Recent publications highlight Clostridioides difficile biofilm dynamics, including bile salt-induced biofilm formation and metabolic adaptations. He also explores biofilm-derived antigens for vaccine design and the role of microbial interactions in biofilm persistence. Teaching & Mentoring: He has supervised 15 undergraduate and 1 graduate student projects, emphasizing student-led research. His teaching spans undergraduate, graduate, and professional programs in microbiology. Labs & Collaborations: Prior affiliations include the Institut Pasteur (Paris) as a Research Associate (2017–2020) and postdoctoral work at the Université de Montréal. His current lab focuses on biofilm biology and translational applications in infection control.

Simon Cuttingمشاهده پروفایل

استاد

• Microbiology
• Vaccinology
• Bacterial Genetics
• +۴ مورد دیگر

Professor Simon Cutting is a distinguished faculty member in the Department of Biological Sciences at Royal Holloway, University of London, where he leads research in microbiology, bacterial genetics, and vaccine development. His work focuses on Bacillus species (particularly B. subtilis), gut microbiome interactions, and developing spore-based vaccines against infectious diseases including Helicobacter pylori, Clostridioides difficile, tuberculosis, and malaria. Professor Cutting's research interests center on microbial pathogenesis, probiotic development, and novel vaccine platforms. His work spans from fundamental bacterial genetics to translational applications, with particular emphasis on how spore-forming bacteria can be engineered for therapeutic purposes. His COLORSSPORE project explores microbial carotenoids, while his INNOVAC initiative develops recombinant vaccines for TB and malaria. The DELPHE Initiative focuses on international higher education partnerships, reflecting his commitment to global scientific collaboration. Analysis of Professor Cutting's recent publications reveals a strong focus on gut microbiome interactions, particularly how Bacillus species can modulate inflammatory responses and combat pathogenic bacteria like Clostridioides difficile and Helicobacter pylori. His work bridges basic microbiology with clinical applications, developing novel therapeutic approaches that leverage bacterial spores as delivery vehicles for vaccines and immunomodulatory compounds. Professor Cutting has secured significant research funding from major organizations including the Medical Research Council, European Commission, and DEFRA/BBSRC. His projects include "Helicobacter pylori in Vietnam: Prevalence, AMR and Vaccination" (2020-2023), "Control of Clostridium Difficile: An Emerging Threat to the European Livestock Industry" (2014-2017), and "Oral Vaccination against Clostridium difficile Infection" (2013-2016). His laboratory at the Centre for Biomedical Sciences investigates Bacillus subtilis genetics and its applications in human health, with particular focus on how bacterial spores can be engineered as vaccine vectors and probiotic therapeutics. Professor Cutting has supervised multiple graduate students and maintains active collaborations with researchers in Vietnam and across Europe.

Mark Wilcoxمشاهده پروفایل

استاد

• Antibiotic Resistance
• Clostridium difficile Infection
• Healthcare-Associated Infections
• +۵ مورد دیگر

Professor Mark Wilcox is a Professor of Medical Microbiology and Sir Edward Brotherton Chair of Bacteriology at the University of Leeds. He serves as the Head of Microbiology Research & Development and Infection Lead of the Leeds NIHR Diagnostic Technologies Co-operative at Leeds Teaching Hospitals NHS Trust. He holds national roles as NHS England’s National Clinical Director for Antimicrobial Resistance (AMR) and Infection Prevention and Control (IPC), and as Public Health England’s lead for Clostridium difficile infection. His expertise spans healthcare-associated infections, antibiotic resistance, diagnostics, and clinical trials of new antimicrobial agents. He chairs PHE’s Rapid Review Panel and sits on multiple national and international committees, including the MRC Infections and Immunity Board and the UK DHSC’s Technical Validation Group for COVID-19 tests. He leads a multidisciplinary research group focusing on C. difficile infection, gut microbiome, and antimicrobial development, with over 560 publications and contributions to major textbooks like Antimicrobial Chemotherapy . His professional qualifications include B Med Sci, BM, BS, MD, and FRCPath. He advises regulatory bodies like FDA/EMA and chairs editorial boards for journals such as Clinical Infectious Diseases . Current research opportunities exist in his group for PhD students interested in infection-related topics.

• Antimicrobial Agents
• Antibiotic Drug Discovery
• Infectious Diseases
• +۳ مورد دیگر

Soumya Ramu is a researcher affiliated with the University of Queensland's Frazer Institute, focusing on antimicrobial drug discovery and antibiotic development. Her work spans antibacterial, antifungal, and antiparasitic compounds with an emphasis on overcoming antibiotic resistance mechanisms. Research Interests: Ms. Ramu's research includes developing novel antibiotics against drug-resistant bacteria, evaluating existing drugs for repurposing (e.g., cannabidiol), and studying chemical agents targeting biofilm-associated infections. She explores metal-ion complexation effects on antibiotic activity and investigates mechanisms of bacterial resistance. Collaborations: Her work involves interdisciplinary teams across medicinal chemistry, microbiology, and pharmacology, collaborating with institutions like the Translational Research Institute and global researchers in antibiotic development. Publications: Ramu's 24+ journal articles and conference papers (2012-2022) highlight contributions to antibiotic design, resistance mechanisms, and drug-activity optimization. Key topics include lipoglycopeptides for biofilm infections, platinum-based antibacterial complexes, and minor groove binder therapeutics.

Julian Hurdleمشاهده پروفایل

استاد

• Antibiotic Resistance
• Infectious Diseases
• Chemical Genetics
• +۱۳ مورد دیگر

Julian Hurdle, PhD, is a Professor at Texas A&M University and Director of the Center for Infectious and Inflammatory Diseases (CIID). His research focuses on antibiotic resistance in Clostridium difficile , novel therapeutic strategies, and chemical genetic approaches to pathogenic mechanisms. Research Interests: His multi-disciplinary work bridges high-throughput screening of chemical libraries, target identification via genomics, and in vivo modeling to understand C. difficile resistance and develop therapies. Collaborations with medicinal chemists and clinical scientists drive translational goals. Publications: His 15 most recent articles highlight studies on C. difficile's evolution of resistance, membrane-active antibiotics, and antivirulence strategies. Keywords span Microbiology, Pharmacology, and Chemical Genetics, with sub-fields like toxin-inhibiting mechanisms, phytochemicals, and drug hybridization. Academic Contributions: As Director of the IBT Postdoctoral Program, he mentors researchers in infectious disease innovation. His lab integrates molecular biology, animal models, and clinical data to impact human health.

Susan Zhouمشاهده پروفایل

استاد

• Biosensors
• Bionanotechnology
• Microfluidics
• +۳ مورد دیگر

Susan Zhou is a Professor in the Department of Chemical Engineering at Worcester Polytechnic Institute (WPI). Her research focuses on biosensors, bionanotechnology, and microfluidics, with applications in healthcare and infectious disease detection. She teaches Advanced Chemical Processes and Fluid Mechanics, emphasizing project-based learning and global education. Education: MS in Chemical Engineering, Clarkson University, 1999 PhD in Chemical Engineering, University of California, Irvine, 2002 Research Interests: Dr. Zhou's team develops biosensors using microfabrication and nanotechnology, targeting applications in healthcare diagnostics. Key areas include electrochemical (EC), surface plasmon resonance (SPR), and surface-enhanced Raman spectroscopy (SERS) technologies. Recent work includes portable biosensors for viral infections like COVID-19 and durable electrocatalysts for fuel cells. Professional Highlights: Recipient of WPI's Faculty Promotion and Tenure Award (2021) Contributed to WPI's record research funding milestone (2018) Co-developed a biosensor for Clostridium difficile detection featured in the Worcester Business Journal Labs/Teams: Leads research on bio-nanotechnology and electrochemical systems, collaborating with industry and academic partners. Active in mentoring undergraduate and graduate students in interdisciplinary projects.

Amir A. Sadighi Akhaمشاهده پروفایل

پژوهشگر

• Immunology
• Clinical Immunology
• Autoimmune Disorders
• +۴ مورد دیگر

Amir A. Sadighi Akha, M.D., Ph.D., is a faculty member at the Mayo Clinic Department of Laboratory Medicine and Pathology. He holds a D.Phil in Immunology from the University of Oxford and an M.D. from the University of Tehran School of Medicine, with postdoctoral training in immunopathology at Johns Hopkins University School of Medicine. Education 1999: Fellow, Immunopathology & Pediatric Immunology, Johns Hopkins University 1996: D.Phil in Immunology, University of Oxford 1991: M.D., University of Tehran His research focuses on immunological mechanisms in aging, autoimmune disorders, and clinical cytometry for immunodeficiencies. Recent work includes: Development of diagnostic frameworks for primary immunodeficiencies Investigation of genetic variants in immune dysregulation Multiomics modeling for predictive biomarkers in infectious diseases Studies on cytokine signaling and mucosal immunity in mouse models Notable scientific awards include the 1991 Iranian Presidential Certificate of Appreciation for top graduate status and the 2004 Keble College Senior Common Room appointment. Professional Memberships Clinical Immunology Society (2025–present) Federation of Clinical Immunology Societies (2024–present) Association of Medical Laboratory Immunologists (2023–present) He contributes to Mayo Clinic's Centers of Excellence and pediatric clinical programs, with expertise in flow cytometry and anti-cytokine autoantibody analysis.

Sabesan Yoganathanمشاهده پروفایل

دانشیار

• Medicinal Chemistry
• Drug Discovery
• Natural Products
• +۵ مورد دیگر

Sabesan Yoganathan is an Associate Professor in the Department of Pharmaceutical Sciences at St. John's University, part of the College of Pharmacy and Health Sciences. He joined the faculty in 2014 after completing a postdoctoral fellowship at Yale University under Professor Scott Miller. His research focuses on developing chemical and biological approaches to discover novel medicinal natural products and their analogs, targeting infectious diseases and cancer. Dr. Yoganathan holds a PhD in Chemistry from the University of Alberta and a BS in Chemistry (Biological Specialization) from McMaster University. His educational background includes undergraduate training at McMaster University as an NSERC research fellow, followed by doctoral research under Professor John Vederas at the University of Alberta. His postdoctoral work at Yale advanced peptide-based catalysis for site-selective modification of natural products like daptomycin and vancomycin, enabling the creation of drug analogs. Research Interests: The Yoganathan lab integrates chemistry and biology to design new drug candidates, including studies on multidrug resistance mechanisms, peptide-based catalysis, and natural product synthesis. Key areas include benzimidazole derivatives for cancer therapy, nanoparticle-based antimicrobials, and overcoming ABC transporter-mediated resistance in cancer cells. Teaching Contributions: He teaches advanced medicinal chemistry courses (e.g., PHS 3508, PHR 5106) to Pharm.D. students and mentors graduate/undergraduate researchers. His team explores topics like synthetic methodologies for drug analogs and drug delivery systems. Labs & Teams: The interdisciplinary Yoganathan Lab emphasizes translational research, with recent successes in preclinical drug development, nanomedicine, and drug repurposing strategies. The lab collaborates on projects such as novel BMP receptor agonists and inflammation-modulating agents for preterm birth prevention.

• Global Health
• Environmental Health
• Infectious Disease
• +۳ مورد دیگر

L. Scott Benson is an Associate Professor in the Department of Family & Preventive Medicine at the University of Utah. His work spans global health, environmental health, and infectious disease, with field research conducted in the Dominican Republic, Puerto Rico, Ghana, Peru, and India. He teaches, consults with infectious disease patients, and collaborates on international projects. Education: MD (University of Utah), PhD (University of Utah), MPH (Utah State University), BS (Brigham Young University) Dr. Benson’s research focuses on the intersection of public health and environmental factors, including studies on global health ethics, antimicrobial resistance, and health disparities in rural populations. His publications reflect a commitment to addressing challenges in low-resource settings through epidemiological and qualitative approaches. His recent articles highlight trends in travel medicine (e.g., travelers' diarrhea), pandemic modeling, and environmental health research, including water quality and biofilm-mediated gene transfer. While no formal awards are listed, his collaborations span clinical, environmental, and global health domains.